Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDIFAST, INC.

(MED)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/10/2021 06/11/2021 06/14/2021 06/15/2021 06/16/2021 Date
290.39(c) 289.49(c) 279.97(c) 282.18(c) 272.67 Last
112 110 129 381 116 228 126 605 95 376 Volume
-1.01% -0.31% -3.29% +0.79% -3.37% Change
More quotes
Financials (USD)
Sales 2021 1 436 M - -
Net income 2021 160 M - -
Net cash position 2021 219 M - -
P/E ratio 2021 21,0x
Yield 2021 -
Sales 2022 1 554 M - -
Net income 2022 174 M - -
Net cash position 2022 274 M - -
P/E ratio 2022 19,3x
Yield 2022 -
Capitalization 3 304 M 3 304 M -
EV / Sales 2021 2,15x
EV / Sales 2022 1,95x
Nbr of Employees 713
Free-Float 95,0%
More Financials
Company
Medifast, Inc. produces, distributes and sells weight loss, weight management, and healthy living products, and other consumable health and nutritional products. The Company’s product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products, and vitamins. Its business units include Optavia, Medifast Direct, Franchise Medifast Weight Control Centers (MWCC) and... 
Sector
Food Processing
Calendar
08/05Earnings Release
More about the company
Ratings of Medifast, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about MEDIFAST, INC.
06/15INSIDER TRENDS : Medifast Insider Extends 90-Day Selling Trend
MT
06/03MEDIFAST  : Declares Unchanged Quarterly Dividend of $1.42 Per Share, Payable Au..
MT
06/03MEDIFAST  : Announces Quarterly Dividend (Form 8-K)
PU
06/03MEDIFAST INC  : Submission of Matters to a Vote of Security Holders, Other Event..
AQ
06/03MEDIFAST, INC.  : Announces Quarterly Dividend
PR
05/21INSIDER TRENDS : 90-Day Insider Buying Trend Reduced with Disposition of Medifas..
MT
05/05MEDIFAST  : DA Davidson Adjusts Price Target on Medifast to $395 From $302, Main..
MT
05/05MEDIFAST  : B. Riley Raises Medifast's PT to $400 from $310 After Q1 Results Top..
MT
05/04MEDIFAST : Q1 Earnings Snapshot
AQ
05/04MEDIFAST  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04MEDIFAST  : Earnings Flash (MED) MEDIFAST Posts Q1 Revenue $340.7M, vs. Street E..
MT
05/04MEDIFAST INC  : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/04MEDIFAST, INC.  : Announces First Quarter 2021 Financial Results
PR
05/04EARNINGS REACTION HISTORY : MEDIFAST INC, 25.0% Follow-Through Indicator, 12.4% ..
MT
05/04WEEKLY PORTFOLIOS REPORT : The buying current continues
More news
News in other languages on MEDIFAST, INC.
05/31LE TOUR D’HORIZON DES ETF  : Des petites valeurs, des millenials et du disruptif
05/10RAPPORT HEBDO PORTEFEUILLES  : Record historique pour nos portefeuilles Europe e..
05/03RAPPORT HEBDO PORTEFEUILLES  : Le courant acheteur perdure
03/29RAPPORT HEBDO PORTEFEUILLES  : Les intervenants se concentrent sur les dossiers ..
03/25Alerte nouveaux achats dans le portefeuille Investisseur USA
More news
Analyst Recommendations on MEDIFAST, INC.
More recommendations
Stock Trading Strategies
MEDIFAST, INC. - 05/17
The underlying trend is to the upside
BUY
More Stock Trading Analysis
Chart MEDIFAST, INC.
Duration : Period :
Medifast, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDIFAST, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 345,00 $
Last Close Price 282,18 $
Spread / Highest target 40,0%
Spread / Average Target 22,3%
Spread / Lowest Target 4,54%
EPS Revisions
Managers and Directors
NameTitle
Daniel R. Chard Executive Chairman & Chief Executive Officer
James P. Maloney Chief Financial Officer
William Baker Executive Vice President-Information Technology
Kevin G. Byrnes Independent Director
Jeffrey J. Brown Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDIFAST, INC.42.59%3 304
BY-HEALTH CO., LTD.45.42%8 668
HERBALIFE NUTRITION LTD.8.10%5 611
BALCHEM CORPORATION15.71%4 324
THE SIMPLY GOOD FOODS COMPANY13.07%3 396
USANA HEALTH SCIENCES, INC.33.19%2 078